(1)
Long-Term Safety and Efficacy of Difelikefalin in Subjects With Chronic Kidney Disease–Associated Pruritus: Analysis From KALM-1 and KALM-2. J of Skin 2021, 5 (6), s75. https://doi.org/10.25251/skin.5.supp.75.